RTI Surgical Inc (RTIX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:RTI Surgical Inc (RTIX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6367
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
RTI Surgical Inc (RTI), formerly RTI Biologics Inc is a surgical implant company that offers biologic, metal and synthetic implants. The company’s products include spine implants, surgical specialties, sports medicine implants, cardiothoracic and orthobiologics. It offers spine implants such as demineralized bone matrix powder, anterior cervical plate system, cancellous chips, cequence anterior cervical plate system, and spinal cable system and others. RTI also provides dbm putties, bicortical allograft bone wedges, cellular allogeneic bone graft, whole radius and cortical cancellous spacer among others. The company develops tutoplast tissue sterilization process was developed to sterilize and preserve tissue for implantation. It operates through manufacturing facilities located in the US and Germany. RTI is headquartered in Alachua, Florida, the US.

RTI Surgical Inc (RTIX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
RTI Surgical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
RTI Surgical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
RTI Surgical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
RTI Surgical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
RTI Surgical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
RTI Surgical Inc, Medical Equipment, Deal Details 10
Partnerships 10
RTI Surgical Enters into Licensing Agreement with Oxford Performance Materials 10
Equity Offering 11
RTI Biologics Completes Private Placement Of Shares For US$50 Million 11
Asset Transactions 12
A&E Medical Acquires Cardiothoracic Closure Business from RTI Surgical for up to USD60 Million 12
Acquisition 13
RTI Surgical to Acquire Zyga Technology 13
Krensavage Partners Acquires 6% Stake in RTI Surgical 14
RTI Biologics Completes Acquisition Of Pioneer Surgical Technology For US$130 Million 15
RTI Surgical Inc – Key Competitors 17
RTI Surgical Inc – Key Employees 18
RTI Surgical Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Aug 02, 2018: RTI Surgical announces second quarter 2018 results 21
May 03, 2018: RTI Surgical Announces First Quarter 2018 Results 23
Mar 01, 2018: RTI Surgical Announces Fourth Quarter and Full Year 2017 Results 25
Nov 02, 2017: RTI Surgical Announces 2017 Third Quarter Results 27
Aug 08, 2017: RTI Surgical Announces 2017 Second Quarter Results 29
Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results 31
Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth 32
Corporate Communications 34
Sep 18, 2017: RTI Surgical Continues to Augment Leadership Team to Accelerate its Strategic Direction 34
Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer 36
Product News 37
Oct 20, 2017: RTI Surgical Introduces TETRAfuse 3D Technology Becoming First to Offer 3D Printed Interbody Polymer Optimized to Participate in Fusion 37
Other Significant Developments 38
Apr 04, 2018: RTI Surgical Reaches Global Milestone of Providing 8 Million Biologic Implants with Zero Confirmed Incidence of Implant-Associated Infection 38
Jan 05, 2018: RTI Surgical Outlines 2018 Guidance and Long-Term Goals 39
Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
RTI Surgical Inc, Medical Equipment, Key Facts, 2017 2
RTI Surgical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
RTI Surgical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
RTI Surgical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
RTI Surgical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
RTI Surgical Inc, Deals By Market, 2012 to YTD 2018 8
RTI Surgical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
RTI Surgical Enters into Licensing Agreement with Oxford Performance Materials 10
RTI Biologics Completes Private Placement Of Shares For US$50 Million 11
A&E Medical Acquires Cardiothoracic Closure Business from RTI Surgical for up to USD60 Million 12
RTI Surgical to Acquire Zyga Technology 13
Krensavage Partners Acquires 6% Stake in RTI Surgical 14
RTI Biologics Completes Acquisition Of Pioneer Surgical Technology For US$130 Million 15
RTI Surgical Inc, Key Competitors 17
RTI Surgical Inc, Key Employees 18
RTI Surgical Inc, Other Locations 19
RTI Surgical Inc, Subsidiaries 19

List of Figures
RTI Surgical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
RTI Surgical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
RTI Surgical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
RTI Surgical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
RTI Surgical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
RTI Surgical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
RTI Surgical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[RTI Surgical Inc (RTIX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Japan Steel Works Ltd:企業の戦略・SWOT・財務情報
    The Japan Steel Works Ltd - Strategy, SWOT and Corporate Finance Report Summary The Japan Steel Works Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Blue Cross Blue Shield of Michigan:企業の戦略・SWOT・財務情報
    Blue Cross Blue Shield of Michigan - Strategy, SWOT and Corporate Finance Report Summary Blue Cross Blue Shield of Michigan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Genisphere LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Genisphere LLC (Genisphere) is a nanotechnology company that provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapeutics. It develops pipeline product …
  • Norgine BV:医療機器:M&Aディール及び事業提携情報
    Summary Norgine BV (Norgine) is a pharmaceutical company that offers medicinal products. The company develops drugs in the therapeutic areas of gastroenterology, incontinence, hepatology and critical and supportive care and pain management, among others. It offers the treatment of diseases related t …
  • RCL Foods Ltd. (RCL):企業の財務・戦略的SWOT分析
    RCL Foods Ltd. (RCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • JD Sports Fashion Plc:企業のM&A・事業提携・投資動向
    JD Sports Fashion Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JD Sports Fashion Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • REV Group Inc (REVG):企業の財務・戦略的SWOT分析
    REV Group Inc (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Enterome Bioscience SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Enterome Bioscience SA (Enterome) is a drug development company which develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome …
  • Spire Inc (SR):企業の財務・戦略的SWOT分析
    Spire Inc (SR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • GOBARTO S.A.:戦略・SWOT・企業財務分析
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Medpace Holdings Inc (MEDP):企業の財務・戦略的SWOT分析
    Medpace Holdings Inc (MEDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Spark Infrastructure Group (SKI):企業の財務・戦略的SWOT分析
    Spark Infrastructure Group (SKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • XCyton Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary XCyton Diagnostics Ltd (Xcyton) is a molecular biology company that develops and markets diagnostics products and services. The company provides ELISA kit for the detection of HIV infection; ELISA products for the detection of Neurocysticercosis, Hepatitis C and Japanese encephalitis. It pro …
  • Centrais Eletricas de Santa Catarina SA (CLSC4):企業の財務・戦略的SWOT分析
    Centrais Eletricas de Santa Catarina SA (CLSC4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Shanxi Zhendong Pharmaceutical Co Ltd (300158):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanxi Zhendong Pharmaceutical Co Ltd (Zhendong Group) is a pharmaceutical company. The company researches, develops, manufactures and markets pharmaceutical products and Chinese medicines in China. It offers products such as cancer drugs, cardiovascular drugs, infectious disease drugs, resp …
  • BioRestorative Therapies Inc (BRTX):企業の財務・戦略的SWOT分析
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • MSIG Insurance (Singapore) Pte. Ltd.:企業の戦略・SWOT・財務情報
    MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • HD Supply, Inc. (HDS):企業の財務・戦略的SWOT分析
    HD Supply, Inc. (HDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tanabe Research Laboratories USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tanabe Research Laboratories USA Inc (TRL), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a healthcare research center that discovers biological drugs. The center conducts research on metabolics, inflammation and immunology. Its products are used for the therapy of serious diseases with …
  • Dexcel PT Israel Ltd:企業の戦略的SWOT分析
    Dexcel PT Israel Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆